Obatoclax
Showing 1 - 19 of 19
Lymphoma, Follicular Trial in Hackensack (Obatoclax mesylate, Rituximab)
Completed
- Lymphoma, Follicular
- Obatoclax mesylate
- Rituximab
-
Hackensack, New JerseyThe Cancer Center at Hackensack University Medical Center
Jul 20, 2016
Metastatic Melanoma Trial in Philadelphia (Obatoclax Mesylate, Temozolomide)
Terminated
- Metastatic Melanoma
- Obatoclax Mesylate
- Temozolomide
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jul 20, 2016
Obatoclax Mesylate in Samples From Young Acute Myeloid Leukemia
Completed
- Leukemia
- gene expression analysis
- +6 more
- (no location specified)
May 17, 2016
Extensive-stage Small Cell Lung Cancer Trial in Worldwide (Obatoclax, Carboplatin/etoposide)
Completed
- Extensive-stage Small Cell Lung Cancer
- Obatoclax
- Carboplatin/etoposide
-
Huntsville, Alabama
- +74 more
Jul 19, 2016
Adult Non-Hodgkin Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Duarte
Terminated
- Adult Non-Hodgkin Lymphoma
- +7 more
- obatoclax mesylate
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 3, 2015
Recurrent Small Cell Lung Cancer, Solid Tumor Trial in Baltimore, New York (obatoclax mesylate, topotecan HCl, laboratory
Completed
- Recurrent Small Cell Lung Cancer
- Unspecified Adult Solid Tumor, Protocol Specific
- obatoclax mesylate
- +2 more
-
Baltimore, Maryland
- +1 more
Apr 14, 2015
Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Rochester (obatoclax mesylate,
Terminated
- Refractory Multiple Myeloma
- +3 more
- obatoclax mesylate
- +2 more
-
Rochester, MinnesotaMayo Clinic
Jan 9, 2015
Hematological Malignancies Trial in Washington, Houston, Toronto (Obatoclax mesylate (GX15-070MS))
Completed
- Hematological Malignancies
- Obatoclax mesylate (GX15-070MS)
-
Washington, District of Columbia
- +2 more
May 9, 2014
B-cell Chronic Lymphocytic Leukemia, Leukemia, Prolymphocytic Leukemia Trial in Boston (drug, biological, other)
Terminated
- B-cell Chronic Lymphocytic Leukemia
- +7 more
- obatoclax mesylate
- +3 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Sep 27, 2013
AML Trial in Canada, United States (Obatoclax)
Completed
- AML
- Obatoclax
-
Chicago, Illinois
- +12 more
Aug 16, 2013
Myelofibrosis Trial in Canada, United States (Obatoclax mesylate (GX15-070MS))
Completed
- Myelofibrosis
- Obatoclax mesylate (GX15-070MS)
-
Washington, District of Columbia
- +6 more
Aug 16, 2013
MDS Trial in Canada, United States (Obatoclax mesylate (GX15-070MS))
Completed
- Myelodysplastic Syndromes
- Obatoclax mesylate (GX15-070MS)
-
Stanford, California
- +21 more
Aug 16, 2013
MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Columbus (bendamustine HCl, obatoclax
Withdrawn
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +6 more
- bendamustine hydrochloride
- +2 more
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Jun 5, 2013
Extensive-stage Small Cell Lung Cancer Trial (Obatoclax Mesylate, Carboplatine and Etoposide, Carboplatin and Etoposide)
Withdrawn
- Extensive-stage Small Cell Lung Cancer
- Obatoclax Mesylate, Carboplatine and Etoposide
- Carboplatin and Etoposide
- (no location specified)
Aug 14, 2012
Hodgkin's Lymphoma Trial in Houston (Obatoclax mesylate (GX15-070MS))
Completed
- Hodgkin's Lymphoma
- Obatoclax mesylate (GX15-070MS)
-
Houston, TexasMD Anderson Cancer Center
Aug 3, 2012
Leukemia, Systemic Mastocytosis Trial in Houston (Obatoclax Mesylate)
Terminated
- Leukemia
- Systemic Mastocytosis
- Obatoclax Mesylate
-
Houston, TexasUT MD Anderson Cancer Center
Oct 14, 2011